Perillyl Alcohol in Treating Patients With Refractory Cancer

Clinical trial NCT00002862 · COMPLETED

Trial details

NCT number: NCT00002862
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1996-10-01
Primary completion: 2001-04-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.